Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications Original Research Article
Author/Authors :
NR Poulter، نويسنده , , CL Chang، نويسنده , , TMM Farley، نويسنده , , O Meirik and the WHO Collaborative Study of Cardiovascular Disease and Steroid HormoneContraception، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1999
Pages :
1
From page :
1610
To page :
1610
Abstract :
Data from the WHO Collaborative Study suggest that use of progestagen preparations with therapeutic indications are associated with a significantly increased risk of venous thromboembolism but not stroke or myocardial infarction.
